Publications in the M&A environment
The Institute for Mergers, Acquisitions and Alliances is a not-for-profit think tank and the only globally recognized association for M&A. We help create a successful M&A culture, from entry to board level.
We are providing world leading research and M&A publications from well known institutions and companies.
Revisiting And Reinforcing The Farmers Fox Theory: A Study (Test) Of Three Cases Of Cross-Border Inbound Acquisition Transactions
by Elsevier Ltd.
This paper aims to revisit and reinforce the early development of Farmers Fox Theory (Reddy et al., 2014a) by analysing three cases in the cross-border inbound acquisitions stream. A qualitative case method is adopted to explore the findings from the sample cases, which are the Vodafone–Hutchison telecom deal, the Bharti Airtel–MTN broken telecom deal, and the Vedanta–Cairn India oil deal. We highlight discussions on organizational factors, due diligence issues, deal characteristics, and country-specific determinants. […] Read more
Most companies tend to accumulate a large information technology (IT) application portfolio over time, especially if they grow through M&A and do not fully integrate operations and assets after each transaction. When viewed holistically, many of these applications may not align with the company’s overall M&A strategy; they were created as point-in-time solutions and don’t necessarily support post-deal, enterprise-level, business and organizational objectives. […] Read more
Rapidly growing companies in the developing world can prepare themselves to do battle on a global stage by gaining access to vital capabilities through acquisitions or partnerships. It is extremely difficult for emerging market economies to sustain the rapid growth that stems from industrialization. […] Read more
As Albert Einstein shrewdly remarked: “If you always do what you always did, you will always get what you always got.” In the consumer marketplace in the 21st century we live in an age where innovation and reinvention is the key to growth. That is the challenge – and opportunity. […] Read more
Following a five-year slowdown in banking sector mergers and acquisitions (M&A), 2015 activity appears to be poised for a rebound across both small and large regional banks. At the same time, the global banking sector is expected to continue its pruning of non-strategic businesses and/or duplicative operational centers, creating opportunities for further business system rationalization and increasing focus on areas of specialization. […] Read more
by A.T. Kearney
Like athletes in training, frequent buyers build acquisition muscle that empowers them to do more deals and do them more effectively. In our recent analysis of acquisitions and value creation at 500 public companies in developed markets, frequent buyers – those with more than one acquisition on average per year – increase value faster and Wall Street puts higher value on these buyers over infrequent buyers. […] Read more
We are expecting 2015 to end with over $4 trillion worth of deals making it the highest for deal values since 2007. However, on a last-twelve-months (LTM) basis, there was a slowdown in the volume of transactions in the second half of 2015. Cross-border deals are a major feature of this M&A wave. More than $1 trillion worth of cross-border deals have been announced so far this year, of which a third were in the vibrant deal corridor between North America and Europe. […] Read more
Opportunities And Challenges Of Value Creation Through Merger And Acquisitions In Cyclical Economies
by Elsevier Ltd.
Despite prevailing financial turmoil and economic uncertainty, global M&A market has shown in 2014 an unseen growth since sub-prime crisis. The research focuses on reaching understanding and reconstructions on how management and corporate strategists can benefit from opportunities arising during various economic cycles. […] Read more
by Ernst & Young
As the specialty pharmaceutical sector sees its ability to pursue large acquisitions evaporate, long-promised organic growth from big pharma new drug launches has finally arrived. But a renewed focus on value-based pricing, staunch competition across key therapeutic battlefields and consolidating payer clout may weaken the industry’s ability to reach revenue targets for both new and legacy therapeutics. […] Read more
by Ernst & Young
Deals that bring companies together often happen at high speed, which creates the potential for missing some critical risks. Everyone in the business world knows that M&A is shorthand for mergers and acquisitions, but these days you could just as readily believe it stands for “moving ahead.” If nothing else, the numbers alone should get the attention of board members at a time when an increasingly holistic view must be taken in every stage of the transaction, including strategy, due diligence, deal approval, integration and post-integration. […] Read more